# A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)

> **NCT01021462** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **PROCEDURE:** Comparator: graded infusion of intravenous glucose

## Key facts

- **NCT ID:** NCT01021462
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2007-08
- **Final completion:** 2007-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021462, "A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01021462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*